The webinar is Jointly organised by the ACGS QSC, RCPath Genomics SAC, AMP and BIVDA. In Vitro Diagnostics (IVDs) play a critical role in healthcare, enabling accurate disease detection, monitoring, and treatment decisions. With regulatory landscapes evolving across the UK, EU, and USA, staying informed is essential for compliance and market success.

TOPICS COVERED

Join us for an exclusive webinar featuring expert insights on the latest IVD related updates from the UK, EU, and USA.
What to Expect:

• Three expert-led talks (30 minutes each) covering key regulatory developments:
• US Perspectives – AMP members closely involved in the FDA lawsuit
• EU Insights – Speakers from BioMedAlliance
• UK Updates – Speakers from BIVDA and MHRA.

WHO SHOULD ATTEND?

Healthcare Scientific and Clinical Diagnostic providers, industry and policy advisors.

SPEAKERS

Speakers from AMP, BioMedAlllicance, MHRA and BIVDA.

• Angela Douglas, President of BIVDA. Former NHSE CSO deputy
• Annie Scrimenti, AMP’s Director of Policy and Advocacy
• Eric Q. Konnick, Dr. Konnick is a board-certified pathologist at Seattle Cancer Care Alliance and UW Medical Center, a UW assistant professor of Laboratory Medicine &Pathology and associate director of UW Medicine’s Genetics and Solid Tumor Lab.
• Sian Morgan, Chair of the Genomics SAC at RCPath
• Michael Neumaier, Chair of the IVDR Taskforce of BioMed Alliance Laboratory Physician and certified EU Clinical Chemist
• Laurie S. Menser, Chief Executive Officer of AMP
• For more information, please contact: [email protected].